PEDIATRICS Vol. 79 No. 6 June 1987, pp. 858-863
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arrowsmith, J. B.
Right arrow Articles by Faich, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arrowsmith, J. B.
Right arrow Articles by Faich, G. A.

National Patterns of Aspirin Use and Reye Syndrome Reporting, United States, 1980 to 1985

Janet B. Arrowsmith MD1, Dianne L. Kennedy MPH1, Joel N. Kuritsky MD1, and Gerald A. Faich MD, MPH1

1 From the Office of Epidemiology and Biostatistics, Center for Drugs and Biologics, Food and Drug Administration, Rockville, Maryland

The number of cases of Reye syndrome reported annually to the Centers for Disease Control declined markedly between 1980 and 1985. In this article, we present pharmaceutical marketing research data that suggest sharp decreases in the use and purchase of children's aspirin between 1980 and 1985. These trends appear to correspond to the decrease in reporting of Reye syndrome cases. Additionally, analysis of physician mentions of aspirin and acetaminophen for treating flu and chickenpox showed statistically significant trends toward decreasing recommendations for the use of aspirin and significant trends toward increasing recommendations for use of acetaminophen. Trends in wholesale purchases of aspirin and acetaminophen by drug stores from 1979 through 1985 demonstrated a significant decline for the 81-mg children's aspirin tablet and an increase in purchases of children's acetaminophen products. Many factors may influence physician and parents' choice of analgesic/antipyretic medication, including information about Reye syndrome. Data suggest that a continuing decline in the use of aspirin for children may be accompanied by a continuing decline in the reported number of Reye syndrome cases.

Key Words: nonprescription drug • aspirin • acetaminophen • Reye syndrome

Submitted on February 18, 1986
Accepted on October 28, 1986




This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
A. Varner
Re: Trends in Reported Incidence of Primary Malignant Brain Tumors in Children in the United States
J Natl Cancer Inst, June 2, 1999; 91(11): 973a - 973a.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. A. Smith, B. Freidlin, L. A. G. Ries, and R. Simon
RESPONSE: Re: Trends in Reported Incidence of Primary Malignant Brain Tumors in Children in the United States
J Natl Cancer Inst, June 2, 1999; 91(11): 973b - 974b.
[Full Text] [PDF]

Home page
 NEJMHome page
E. D. Belay, J. S. Bresee, R. C. Holman, A. S. Khan, A. Shahriari, and L. B. Schonberger
Reye's Syndrome in the United States from 1981 through 1997
N. Engl. J. Med., May 6, 1999; 340(18): 1377 - 1382.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. E. Kauffman
Reye's Syndrome and Salicylate Use, by Karen M. Starko, MD, et al, Pediatrics, 1980;66:859-864; and National Patterns of Aspirin Use and Reye Syndrome Reporting, United States, 1980 to 1985, by Janet B. Arrowsmith et al, Pediatrics, 1987;79:858-863
Pediatrics, July 1, 1998; 102(1): 259 - 262.
[Full Text]